BMS-986202
IM016-006
Phase 1 small_molecule completed
Quick answer
BMS-986202 for Psoriasis is a Phase 1 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Psoriasis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed